Screening in Women With BRCA Mutations Revisited. Review uri icon

Overview

abstract

  • Patients with BRCA1 or BRCA2 gene mutations are at high risk for the development of breast cancer. This article reviews the current evidence for breast cancer screening of patients with BRCA1 or BRCA2 pathogenic gene mutations if they have not undergone prophylactic mastectomy. It will review the current evidence-based imaging recommendations for different modalities and ages of screening initiation in screening this patient population at high risk. Special considerations in transgender BRCA1 and BRCA2 mutation carriers are also discussed.

publication date

  • January 19, 2024

Research

keywords

  • Breast Neoplasms

Identity

Scopus Document Identifier

  • 85182881350

Digital Object Identifier (DOI)

  • 10.1093/jbi/wbad093

PubMed ID

  • 38166173

Additional Document Info

volume

  • 6

issue

  • 1